Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPWTi-d vs. Collagenase for Full-thickness Wounds
NCT03722485Terminated
- Sponsor
- KCI
- Start
- Dec 2018
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by KCI. Primary endpoint: Absolute Change in the Percentage of Wound Bed Surface Area (%) Considered Clean, Healthy and Viable. Started Dec 2018; status: terminated.
Beyond the preview
Go deeper on NCT03722485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03722485.